The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorJichao Qin

About this trial

This study aims to examine the predictive value of metastatic gastric mesenteries, which contains metastatic lymph node, in 6 gastric mesenteries; and importantly, to further evaluate the relationship between the number of metastatic gastric mesenteries and prognosis in the gastric cancer patients who received D2+complete mesogastric excision (CME).

Eligibility criteria

Qualifiers

Aged older than 18 years and younger than 85 years

Primary gastric adenocarcinoma confirmed by preoperative pathology result

cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition

Patients who received gastrectomy with D2 lymphadenectomy plus complete mesogastric excision

Disqualifiers

Negative preoperative biopsy

Too late tumour stage or metastasis (cT4b/M1)

BMI>30 kg/m2

Total gastrectomy or proximal gastrectomy

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

400 Participants
are grouped into 1 trial group

Sponsors and collaborators

Jichao Qin

Lead sponsor

First Affiliated Hospital of Zhejiang University

Sponsor institution

Zhejiang University

Collaborator